Expression of MAGE-A and NY-ESO-1 cancer/testis antigens is enriched in triple-negative invasive breast cancers
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of MAGE-A and NY-ESO-1 cancer/testis antigens is enriched in triple-negative invasive breast cancers
Authors
Keywords
-
Journal
HISTOPATHOLOGY
Volume 73, Issue 1, Pages 68-80
Publisher
Wiley
Online
2018-02-22
DOI
10.1111/his.13498
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer
- (2017) S Hernández-Pérez et al. ONCOGENE
- Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells
- (2017) Cornelia Siebenkäs et al. PLoS One
- Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer
- (2017) Sathana Dushyanthen et al. Nature Communications
- Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity
- (2017) Ruth Dannenfelser et al. Oncotarget
- Triple-Negative Breast Cancer: Current Practice and Future Directions
- (2017) Ricardo L.B. Costa et al. Journal of Oncology Practice
- Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis
- (2016) Mohammad A. Aleskandarany et al. BREAST CANCER RESEARCH AND TREATMENT
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- SASH1 mediates sensitivity of breast cancer cells to chloropyramine and is associated with prognosis in breast cancer
- (2016) Joshua T. Burgess et al. Oncotarget
- RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
- (2015) S. Loi et al. CLINICAL CANCER RESEARCH
- Cancer/Testis Antigens Trigger Epithelial-Mesenchymal Transition and Genesis of Cancer Stem-Like Cells
- (2015) Ping Yang et al. CURRENT PHARMACEUTICAL DESIGN
- Novel highly specific anti-periostin antibodies uncover the functional importance of the fascilin 1-1 domain and highlight preferential expression of periostin in aggressive breast cancer
- (2015) Sarah Field et al. INTERNATIONAL JOURNAL OF CANCER
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype
- (2015) Simon Junankar et al. Nature Communications
- A Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers
- (2015) Yong-Chen Lu et al. Journal for ImmunoTherapy of Cancer
- MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4
- (2015) Lynnette Marcar et al. PLoS One
- Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
- (2014) S. Loi et al. ANNALS OF ONCOLOGY
- Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
- (2014) M. D. Burstein et al. CLINICAL CANCER RESEARCH
- Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
- (2014) Sylvia Adams et al. JOURNAL OF CLINICAL ONCOLOGY
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chromosome instability induced by Mps1 and p53 mutation generates aggressive lymphomas exhibiting aneuploidy-induced stress
- (2014) Floris Foijer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- Erratum: Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
- (2014) F Al-Ejeh et al. Oncogenesis
- Derepression of Cancer/Testis Antigens in cancer is associated with distinct patterns of DNA Hypomethylation
- (2013) Robert Kim et al. BMC CANCER
- Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
- (2013) Sherene Loi et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial
- (2013) David Cameron et al. LANCET ONCOLOGY
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Whole chromosome instability resulting from the synergistic effects of pRB and p53 inactivation
- (2013) A L Manning et al. ONCOGENE
- TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
- (2013) Virginie Maire et al. PLoS One
- Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
- (2013) John Stagg et al. Therapeutic Advances in Medical Oncology
- Centrosomes, chromosome instability (CIN) and aneuploidy
- (2012) Benjamin D Vitre et al. CURRENT OPINION IN CELL BIOLOGY
- Chromosomal instability and cancer: a complex relationship with therapeutic potential
- (2012) Samuel F. Bakhoum et al. JOURNAL OF CLINICAL INVESTIGATION
- Erratum to: High expression of MAGE-A10 cancer-testis antigen in triple-negative breast cancer
- (2012) Tanja Badovinac-Črnjević et al. MEDICAL ONCOLOGY
- NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
- (2012) Foluso O. Ademuyiwa et al. PLoS One
- The Role of MAGEA2 in Head and Neck Cancer
- (2011) Chad A. Glazer et al. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple Cancer/Testis Antigens Are Preferentially Expressed in Hormone-Receptor Negative and High-Grade Breast Cancers
- (2011) Yao-Tseng Chen et al. PLoS One
- Chromosome Segregation Errors as a Cause of DNA Damage and Structural Chromosome Aberrations
- (2011) A. Janssen et al. SCIENCE
- Cancer-testis antigen expression in triple-negative breast cancer
- (2010) G. Curigliano et al. ANNALS OF ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
- (2009) Elgene Lim et al. NATURE MEDICINE
- CT-X antigen expression in human breast cancer
- (2009) A. Grigoriadis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MAGE-A and NY-ESO-1 expression in cervical cancer: Prognostic factors and effects of chemotherapy
- (2008) Chiara Napoletano et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search